Great post, Goose. I admit my unbridled optimism has

New Post Public Reply Private Reply Replies (0) Message Board
USS JOHNSTON Goosebumps #121749
1,316
Great post, Goose. I admit my unbridled optimism has diminished over the last year for a SP spike . . .

- after I learned what the FDA did to our CD-12 trial design (2 vs 4),
- after I learned how the DSMB failed to give us a heads-up on the 3:1 imbalance of older patients in our LL arm vs control,
- after the FDA slammed our 'subgroup results' (even though they were so much better than Remdeath),
- after we got publicly scolded and denied a COVID EUA,
- after the Philippines fell off the map,
- after our trusted/experienced CRO seemingly deliberately botched (for years) our HIV data submissions,
- after Canada and Mexico fell off the map,
- after so many hospitals in Brazil, we only got 9 critical patients after approx 5 months.
- after the FDA slammed us AGAIN with a public letter (for what, I'm still not sure, I thought the FDA's charter was to just ensure the drugs they APPROVE are safe/effective)
- after so many reprehensible idiots spout so many outright lies/FUD on both the ihub and yahoo boards literally every hour of every day 24/7/365, thus proving they MUST be funded by an entity that wants Cytodyn to fail (and by extension, for people to die).

I see these things during a pandemic with no approved therapeutic that works, and I know the mountain before us isn't poorly designed trials or poor leadership or an ineffective drug. Our mountain is a corrupt FDA and BP companies that will do anything to sabotage our trials, including killing patients by blocking our drug.

I don't know how we climb this mountain, how we defeat the unholy alliance of BP/FDA rot. I suppose all we can do is what we are doing, e.g., hire the best law firm we can, partner with a (hopefully) not-completely-corrupt BP, and perhaps get an EUA in some nation that cares more about saving their citizens than upsetting BP.

I'm still buying CYDY, I bought 2600 shares last week. This is my one and only investment, and I know financial advisors and anyone with a brain would tell me I'm a financial idiot. Maybe just an idiot. But I've never seen Leronlimab fail.

And I know if I had critical COVID or cancer or frankly any other life-threatening disease, there is NOTHING - aside from a heavenly intercession from Padre Pio - I would want more than Leronlimab.

I'm no MD, but if there ever is such a thing as a medical Holy Grail, we have it.
And like the USS Johnston, despite overwhelming odds, we just have to attack, attack, attack!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 37

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 31

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 30

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 35

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 26

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 34

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 21

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading

Top 5 Most Recently Viewed Articles

Palantir Technologies Sees Surging Growth with AI Innovations

Updated Category News Views 312

Palantir Technologies Thrives on AI Innovations Palantir Technologies (NYSE: PLTR) has greatly benefited from the soaring demand for artificial intelligence (AI) solutions. Known for its cutting-edge AI and data mining services, the company has seen remarkable sales growth and rising profits as a direct result. Recently, Palantir's stock jumped 15% after being chosen for...

Continue Reading
Revolutionizing Senior Care: CarePredict and ALIS Unite

Updated Category News Views 171

Revolutionizing Senior Care with Real-Time Tracking CarePredict, a leader in AI-powered care solutions, has partnered with ALIS by Medtelligent to unveil an innovative approach to senior living care. This collaboration aims to enhance care management for seniors by providing a comprehensive tracking system that bridges the gap between scheduled and actual care services....

Continue Reading
Remark Holdings Showcases AI Innovations at Oracle Cloud Event

Updated Category News Views 44

Remark Holdings at Oracle Cloud World 2024 Remark Holdings, Inc. (OTCQX: MARK), a leader in AI-driven computer vision analytics and smart city solutions, is thrilled to announce its participation in Oracle Cloud World 2024. This significant event will take place at the Venetian Conference and Expo Center, bringing together industry leaders from around the world. An...

Continue Reading
Duthie Power Services Unveils New Website for Better User Experience

Updated Category News Views 166

Duthie Power Services Introduces Redesigned Online Platform Duthie Power Services, a leader in generator solutions for over six decades, is thrilled to announce an exciting development. The company has launched a newly redesigned website, created in collaboration with Digi-Solutions, that puts user experience at the forefront. A Fresh and Modern Look The revitalized...

Continue Reading
Truecaller Shares Buyback Highlights from Week 47, 2025

Updated Category News Views 189

Truecaller AB Share Buyback Update In the latest share buyback report, Truecaller AB (publ) has made significant progress during week 47, which saw a total repurchase of 350,000 B shares. This repurchase represents approximately 0.10% of the company's outstanding capital. So far, since the initiation of the buyback program, Truecaller has acquired a total of 2,954,053...

Continue Reading